Researchers question safety of mist inhalers for delivering common drug for chronic lung disease
Wednesday, June 15, 2011 - 03:30
in Health & Medicine
People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.